Davis, CA, United States of America

David A Mills

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 109(Granted Patents)


Location History:

  • Oakland, CA (US) (2018 - 2019)
  • Davis, CA (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: David A. Mills: Innovations in Glycobiology and Enzyme Technology

Introduction: David A. Mills, an accomplished inventor based in Davis, CA, has made significant contributions to the field of glycobiology with his impressive portfolio of 22 patents. His research focuses on the development of enzymes for the modification of glycoproteins, aiming to enhance our understanding and application of complex carbohydrates in biological systems.

Latest Patents: Among his latest patents, Mills has developed innovative enzyme technologies, including those related to "Enzymes and methods for cleaving N-glycans from glycoproteins." This patent describes the use of deglycosylating enzymes that effectively remove a wide range of N-glycans from proteins. These enzymes can be utilized for various applications, such as producing free glycans for characterization and for enhancing digestion while reducing the immunogenicity of proteins.

Another notable patent addresses "Reduction of milk glycans and their degradation products in the neonate gut." This patent presents methods aimed at decreasing milk glycans, which can serve as carbon sources for enteric pathogens in the guts of nursing mammals. These advancements hold great potential in improving neonatal health and nutrition.

Career Highlights: David A. Mills has cultivated a prominent career in academia and industry, notably with the University of California and DSm Food Specialties USA Inc. His work bridges the gap between research and practical applications, leading to innovations that contribute to various biotechnological advancements.

Collaborations: Throughout his career, Mills has collaborated with esteemed colleagues, including Carlito Bangeles Lebrilla and J. Bruce German. Their joint efforts have further propelled the exploration and enhancement of glycan research, solidifying Mills' reputation in the scientific community.

Conclusion: David A. Mills continues to shape the landscape of glycoprotein research and enzyme technology through his innovative patents and collaborative efforts. His work not only opens new avenues for scientific inquiry but also holds promise for real-world applications that can benefit health and nutrition across multiple domains.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…